Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Soligenix awarded NIAID contract to develop heat stable RiVax vaccine

Sep. 23, 2014

Legalon Sil given FDA orphan designation for amatoxin poisoning

Sep. 22, 2014

Cellerant's development of CLT-008 supported by additional government funding

Sep. 17, 2014

NIAAA to study gabapentin enacarbil for the treatment of alcohol use disorder

Sep. 12, 2014

NIDA awards grant to support completion of phase IIa trial of ibudilast in opioid dependence

Sep. 9, 2014

Cleveland BioLabs clear to submit pre-EUA for entolimod

Sep. 4, 2014

Aldea Pharmaceuticals closes Series B financing

Aug. 26, 2014

Aeolus files IND for acute radiation syndrome candidate AEOL-10150

Aug. 22, 2014

MediciNova discloses results from phase IIa study of ibudilast in opioid dependence

Aug. 20, 2014

NIPER reports novel PON 1 enzymes

Aug. 14, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...